TR199501376A2 - Karbazoller ve siklodekstrinler iceren bilesimler. - Google Patents
Karbazoller ve siklodekstrinler iceren bilesimler.Info
- Publication number
- TR199501376A2 TR199501376A2 TR95/01376A TR9501376A TR199501376A2 TR 199501376 A2 TR199501376 A2 TR 199501376A2 TR 95/01376 A TR95/01376 A TR 95/01376A TR 9501376 A TR9501376 A TR 9501376A TR 199501376 A2 TR199501376 A2 TR 199501376A2
- Authority
- TR
- Turkey
- Prior art keywords
- cyclodextrins
- compounds containing
- carbazoles
- containing carbazoles
- compounds
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94203242 | 1994-11-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199501376A2 true TR199501376A2 (tr) | 1996-06-21 |
Family
ID=8217355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR95/01376A TR199501376A2 (tr) | 1994-11-07 | 1995-11-07 | Karbazoller ve siklodekstrinler iceren bilesimler. |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU3846395A (tr) |
IL (1) | IL115885A0 (tr) |
TR (1) | TR199501376A2 (tr) |
WO (1) | WO1996014090A1 (tr) |
ZA (1) | ZA959388B (tr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ330596A (en) * | 1998-06-05 | 2001-02-23 | Dec Res | Intravaginal devices allowing for increased uptake of active ingredients |
US6683100B2 (en) | 1999-01-19 | 2004-01-27 | Novartis Ag | Organic compounds |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
US7141598B2 (en) | 2000-11-17 | 2006-11-28 | Takeda Pharmaceutical Company, Ltd. | Imidazole derivatives, production method thereof and use thereof |
EP1344777B1 (en) | 2000-11-20 | 2011-03-16 | Takeda Pharmaceutical Company Limited | Imidazole derivatives, process for their preparation and their use |
EP1348706B1 (en) | 2000-12-08 | 2009-08-19 | Takeda Pharmaceutical Company Limited | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
KR101360725B1 (ko) | 2009-06-26 | 2014-02-07 | 노파르티스 아게 | Cyp17의 억제제로서의 1,3-이치환된 이미다졸리딘-2-온 유도체 |
EA201290208A1 (ru) * | 2009-10-23 | 2012-10-30 | Хелт Рисерч Инк. | Способ лечения андроген-рецептор позитивных раковых заболеваний |
CA2807149C (en) | 2010-08-04 | 2017-05-02 | Pellficure Pharmaceuticals, Inc. | Novel treatment of prostate carcinoma |
US8946260B2 (en) | 2010-09-16 | 2015-02-03 | Novartis Ag | 17α-hydroxylase/C17,20-lyase inhibitors |
MX359399B (es) | 2011-04-28 | 2018-09-27 | Novartis Ag | Inhibidores de 17alfa-hidroxilasa/c17-20-liasa. |
CA2902335C (en) | 2013-03-14 | 2021-09-14 | Pellficure Pharmaceuticals, Inc. | Novel therapy for prostate carcinoma |
EP3191087A1 (en) | 2014-09-12 | 2017-07-19 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
EP3528799A1 (en) | 2016-10-24 | 2019-08-28 | Pellficure Pharmaceuticals, Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9310635D0 (en) * | 1993-05-21 | 1993-07-07 | Glaxo Group Ltd | Chemical compounds |
-
1995
- 1995-10-31 AU AU38463/95A patent/AU3846395A/en not_active Abandoned
- 1995-10-31 WO PCT/EP1995/004295 patent/WO1996014090A1/en active Application Filing
- 1995-11-06 IL IL11588595A patent/IL115885A0/xx unknown
- 1995-11-06 ZA ZA959388A patent/ZA959388B/xx unknown
- 1995-11-07 TR TR95/01376A patent/TR199501376A2/tr unknown
Also Published As
Publication number | Publication date |
---|---|
WO1996014090A1 (en) | 1996-05-17 |
IL115885A0 (en) | 1996-01-31 |
ZA959388B (en) | 1997-05-06 |
AU3846395A (en) | 1996-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69636353D1 (de) | Datenübetragungsvorrichtung. | |
NL1004863A1 (nl) | 5-Amino-4-ethylsulfinyl-1-arylpyrazolen. | |
IT1267648B1 (it) | Amplificatore ottico. | |
TR199501376A2 (tr) | Karbazoller ve siklodekstrinler iceren bilesimler. | |
TR199500945A1 (tr) | Sübstitüe edilmis bifeniloksazolinler. | |
ES1028955Y (es) | Auriculares. | |
IT234659Y1 (it) | Sottosella. | |
FR2720962B1 (fr) | Baguetteuse. | |
FR2714950B3 (fr) | Réducteur-variateur. | |
ES1028836Y (es) | Detector. | |
ES1028138Y (es) | Corbatero. | |
ES1029230Y (es) | Hipermeable hipico. | |
ES1028140Y (es) | Bovedilla. | |
ES1030227Y (es) | Felpudo burlete. | |
ES1027494Y (es) | Paellero. | |
ES1038817Y (es) | Guitarra biboca. | |
ITRE940003A0 (it) | Impianto-magazzino. | |
MA23135A1 (fr) | Rouleau-cuvetteur. | |
ITCH940004A0 (it) | Oleomiscelatore lancimix. | |
ES1032568Y (es) | Protector-precinto. | |
ES1029950Y (es) | Interruptor-conmutador. | |
ES1031132Y (es) | Prensa-latas. | |
ES1030500Y (es) | Braga-compresa monouso. | |
ES1032636Y (es) | Osario. | |
ES1032657Y (es) | Banderilla. |